Singleron Completes $30 Million Series A Financing 10.09.20201’Singleron Biotechnologies, a yound and fast-growing company, developing high-throughput single-cell multiomics platform products, announced the successful completion of $30 million Series A financing. Lilly Asia Ventures (LAV) led the investment. Other new investors include CDH Investments, ARCH Venture Partners, Tencent, and China Reform Conson Soochow Overseas Fund I L.P. (managed by CDG Capital). Existing investors Sherpa Healthcare Partners and China Growth Capital also participated in this funding round.Founded in 2018, Singleron has dedicated to applying groundbreaking single cell analysis technologies to clinical diagnosis, drug development and health management. The company currently has offices and laboratories in Nanjing, Suzhou, US and Germany. Singleron will invest the proceeds to further develop single-cell platform products and their clinical applications, to accelerate the commercialization of its proprietary technologies, and to ramp up its international presence.This A round is Singleron’s third round of financing after the seed round and Pre-A round led by Oriza Seed and Sherpa Healthcare Partners in 2018 and 2019, respectively. To date the total funding received by Singleron has exceeded 300 million yuan.Check out our latests news and events Learn more 24.02.02 Singleron Expands Global Presence with New Office and Laboratories in Michigan, USA Singleron, a pioneer in single cell multi-omics solutions, announces the opening of its latest office and labs in Ann Arbor, Michigan, USA, marking a strategic… Read more 24.01.25 Singleron launches the AccuraSCOPE® Single Cell Transcriptome and Genome Library Kit at 2024 Festival of Genomics. Singleron Biotechnologies, a leader in single cell multi-omic solutions for precision medicine, announced two new commercial product launches at the Festival of Genomics meeting in London,… Read more 23.12.13 Virtual twin to improve treatment with cancer immunotherapies An international team started the research project CERTAINTY in December 2023. Together with partners from science, industry and the healthcare sector, the project team led… Read more
24.02.02 Singleron Expands Global Presence with New Office and Laboratories in Michigan, USA Singleron, a pioneer in single cell multi-omics solutions, announces the opening of its latest office and labs in Ann Arbor, Michigan, USA, marking a strategic… Read more
24.01.25 Singleron launches the AccuraSCOPE® Single Cell Transcriptome and Genome Library Kit at 2024 Festival of Genomics. Singleron Biotechnologies, a leader in single cell multi-omic solutions for precision medicine, announced two new commercial product launches at the Festival of Genomics meeting in London,… Read more
23.12.13 Virtual twin to improve treatment with cancer immunotherapies An international team started the research project CERTAINTY in December 2023. Together with partners from science, industry and the healthcare sector, the project team led… Read more